Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells
about
Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor D-1-methyl-tryptophan.Generation of V α13/β21+T cell specific target CML cells by TCR gene transfer.PURIFICATION AND FRACTIONAL ANALYSIS OF METHANOLIC EXTRACT OF WEDELIA TRILOBATA POSSESSING APOPTOTIC AND ANTI-LEUKEMIC ACTIVITY.Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells.CAR-T Cells Based on Novel BCMA Monoclonal Antibody Block Multiple Myeloma Cell Growth
P2860
Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Construction of a new anti-CD1 ...... tudy of the transduced T cells
@en
type
label
Construction of a new anti-CD1 ...... tudy of the transduced T cells
@en
prefLabel
Construction of a new anti-CD1 ...... tudy of the transduced T cells
@en
P2093
P2860
P356
P1433
P1476
Construction of a new anti-CD1 ...... tudy of the transduced T cells
@en
P2093
Haiyan Xing
Jianxiang Wang
Kejing Tang
Zheng Tian
Zhongfei Tao
P2860
P304
10638-10649
P356
10.18632/ONCOTARGET.7079
P407
P577
2016-01-30T00:00:00Z